These terms and conditions govern your use of the website alphaminr.com and its related
services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr,
(“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms
include the provisions in this document as well as those in the Privacy Policy. These terms may
be modified at any time.
Subscription
Your subscription will be on a month to month basis and automatically renew every month. You may
terminate your subscription at any time through your account.
Fees
We will provide you with advance notice of any change in fees.
Usage
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Limitation of Liability
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The
service is provided “As is”. The materials and information accessible through the Service are
solely for informational purposes. While we strive to provide good information and data, we make
no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO
YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY
OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR
(2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE
CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR
CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision
shall not affect the validity or enforceability of the remaining provisions herein.
Privacy Policy
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal
information when we provide our service (“Service”). This Privacy Policy explains how
information is collected about you either directly or indirectly. By using our service, you
acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy
Policy, please do not use our Service. You should contact us if you have questions about it. We
may modify this Privacy Policy periodically.
Personal Information
When you register for our Service, we collect information from you such as your name, email
address and credit card information.
Usage
Like many other websites we use “cookies”, which are small text files that are stored on your
computer or other device that record your preferences and actions, including how you use the
website. You can set your browser or device to refuse all cookies or to alert you when a cookie
is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not
function properly. We collect information when you use our Service. This includes which pages
you visit.
Sharing of Personal Information
We use Google Analytics and we use Stripe for payment processing. We will not share the
information we collect with third parties for promotional purposes.
We may share personal information with law enforcement as required or permitted by law.
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
September 30, 2025
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________ to ___________
Commission File Number:
001-42932
BETA Technologies, Inc.
(Exact Name of Registrant as Specified in its Charter)
Delaware
83-1276474
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1150 Airport Drive
South Burlington
,
Vermont
05403
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code: (
802
)
281-3623
Securities registered pursuant to section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A common stock, par value $0.0001
BETA
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes
o
No
x
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
x
No
o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
o
Accelerated filer
o
Non-accelerated filer
x
Smaller reporting company
o
Emerging growth company
x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
o
No
x
As of December 01, 2025, there were
220,528,649
shares of Class A common stock, $0.0001 par value per share, and
8,501,484
shares of Class B common stock, $0.0001 par value per share, outstanding.
This Quarterly Report on Form 10-Q includes “forward-looking statements” within the meaning of federal securities laws, which statements involve substantial risks and uncertainties. All statements other than statements of historical facts included or incorporated by reference in this report, including, without limitation, statements regarding the Company’s future financial position, business strategy, budgets, projected revenues, projected costs, and plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “could,” “expect,” “intend,” “project,” “estimate,” “anticipate,” “plan,” “believe,” or “continue” or the negative of such terms or similar terminology. Important factors that could cause actual results to differ materially from the Company’s expectations include, but are not limited to, the Company’s assumptions about:
•
our ability to design, manufacture and deliver our aircraft and other offerings to customers;
•
our ability to obtain all required certifications, licenses, approvals, or authorizations from governmental authorities;
•
our ability to achieve our business milestones for the commercialization of our aircraft and other offerings in a timely manner, or at all;
•
the impact of competing products, services, or technologies or technological changes that result in reduced demand for our aircraft or other offerings, or in other adverse effects on the electric and hybrid electric aviation (including Vertical Take-Off and Landing aircraft) industry or our business;
•
our ability to access the capital and credit markets or borrow on affordable terms to obtain additional capital that we may require;
•
our ability to manage and grow our business effectively;
•
risks associated with our defense program and our ability to secure and comply with existing or future contracts or otherwise grow our relationship with the U.S. Military and other U.S. governmental organizations;
•
the potential for losses and adverse publicity stemming from any accidents or other incidents involving aircraft and, in particular, from accidents involving electric aircraft, or battery solutions, such as lithium-ion batteries;
•
natural disasters, outbreaks and pandemics, economic, social, weather, growth constraints, and regulatory conditions;
•
our dependence on suppliers and service partners for raw materials and certain parts and components;
•
threats of cybersecurity-related attacks and other cyber-incidents;
•
our success in retaining or recruiting, or changes in, our officers or other key employees or our directors;
•
our ability to address a wide variety of extensive and evolving laws and regulations with which we are, or may in the future be, required to comply;
•
changes in tax laws or regulations that are applied adversely to us or challenges to our tax positions;
•
claims and litigation that could ultimately be resolved against us;
•
the cost of compliance with governmental regulations, evolving scrutiny, and changing expectations from global regulators and our stakeholders regarding our environmental, social, and governance practices and value proposition;
•
costs incurred in complying with, or liabilities or obligations imposed under, environmental health and safety laws and regulations; and
•
the other factors set forth in “Risk Factors” and elsewhere in the Company’s prospectus, dated November 3, 2025, filed with the Securities and Exchange Commission (the “SEC”) in accordance with Rule 424(b) of the Securities Act of 1933, as amended (the “Securities Act”) on November 4, 2025 (File No. 333-290570) (the “Prospectus”), this Quarterly Report on Form 10-Q, and our subsequent filings with the SEC.
We caution you that the foregoing list may not contain all of the forward-looking statements made in this Quarterly Report on Form 10-Q.
You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Quarterly Report on Form 10-Q primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations, and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors, including those described in the Prospectus and this Quarterly Report on Form 10-Q. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Quarterly Report on Form 10-Q. We cannot assure you that the results, events, and circumstances reflected in the forward-looking statements will be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements.
The forward-looking statements made in this Quarterly Report on Form 10-Q relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report on Form 10-Q to reflect events or circumstances after the date of this Quarterly Report on Form 10-Q or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make.
In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report on Form 10-Q, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.
As used in this Quarterly Report on Form 10-Q, unless otherwise stated or the context requires otherwise, references to “BETA,” the “Company,” “we,” “us,” and “our,” refer to BETA Technologies, Inc. and its consolidated subsidiaries.
(in thousands, except share and per share amounts)
(unaudited)
Part I. Financial Information
Item 1. Financial Statements
September 30, 2025
December 31, 2024
Assets
Current assets:
Cash and cash equivalents
$
687,627
$
301,396
Accounts receivable
(1)
7,683
2,152
Prepaid expenses and other current assets
(1)
17,196
23,791
Total current assets
712,506
327,339
Property and equipment, net
331,706
319,588
Operating lease right-of-use assets
16,582
16,411
Prepaid expenses and other non-current assets
8,543
3,034
Total assets
$
1,069,337
$
666,372
Liabilities, convertible preferred stock and stockholders’ equity
Current liabilities:
Accounts payable
$
13,166
$
16,232
Deferred revenue, current
(2)
3,616
6,401
Operating lease liabilities, current
1,540
1,741
Notes payable, current
5,670
2,835
Accrued expenses and other current liabilities
44,320
29,345
Total current liabilities
68,312
56,554
Deferred revenue, non-current
(2)
12,430
6,360
Operating lease liabilities, non-current
16,995
16,683
Notes payable, non-current
179,103
149,231
Other liabilities
2,608
1,601
Total liabilities
279,448
230,429
Commitments and contingencies (see Note 7)
Convertible preferred stock and stockholders’ equity:
Convertible Series A preferred stock, $
0.00002
par value,
56,088,617
shares authorized, issued and outstanding as of September 30, 2025 and December 31, 2024; liquidation preference of $
640,005
as of September 30, 2025 and December 31, 2024
(3)
624,733
624,733
Convertible Series B preferred stock, $
0.00002
par value,
30,925,502
shares authorized;
25,416,180
shares issued and outstanding as of September 30, 2025 and December 31, 2024; liquidation preference of $
505,263
and $
483,190
as of September 30, 2025 and December 31, 2024, respectively
(3)
491,961
469,889
Convertible Series C preferred stock, $
0.00002
par value,
26,479,034
shares authorized;
26,445,232
and
18,060,773
shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively; liquidation preference of $
494,564
and $
327,561
as of September 30, 2025 and December 31, 2024, respectively
(3)
539,527
316,691
Convertible Series C-1 preferred stock, $
0.00002
par value,
27,872,661
shares authorized;
23,545,451
shares issued and outstanding as of September 30, 2025 and
0
shares issued and outstanding as of December 31, 2024; liquidation preference of $
422,843
and $
0
as of September 30, 2025 and December 31, 2024, respectively
(3)
724,747
—
Common stock, $
0.00002
par value,
239,813,390
and
223,340,884
shares authorized;
37,578,571
and
37,040,639
shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively
(3)
1
1
Common stock, super voting, $
0.00002
par value,
8,501,484
shares authorized, issued, and outstanding as of September 30, 2025 and December 31, 2024
(3)
—
—
Treasury stock
(
5,888
)
(
5,888
)
Additional paid-in capital
—
—
Accumulated deficit
(
1,585,099
)
(
969,276
)
Foreign currency translation adjustments
(
93
)
(
207
)
Total convertible preferred stock and stockholders’ equity
789,889
435,943
Total liabilities, convertible preferred stock and stockholders’ equity
$
1,069,337
$
666,372
______________
(1)
Includes related party amounts of $
2,226
and $
1,473
(accounts receivable) and $
0
and $
9,897
(prepaid expenses and other current assets) as of September 30, 2025, and December 31, 2024, respectively (see Note 14).
(2)
Includes related party amounts of $
1,011
and $
400
(deferred revenue, current) and $
8,545
and $
3,497
(deferred revenue, non-current) as of September 30, 2025, and December 31, 2024, respectively (see Note 14).
(3)
Share amounts have been adjusted to reflect the
6.3811681
-for-1 forward stock split that became effective on November 3, 2025 in connection with the initial public offering (see Note 1).
The accompanying notes are an integral part of these condensed consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(in thousands, except share and per share amounts)
(unaudited)
For the Three Months Ended
September 30,
For the Nine Months Ended
September 30,
2025
2024
2025
2024
Revenues:
Product revenue
(1)
$
2,917
$
799
$
7,993
$
1,395
Service revenue
(1)
6,001
2,267
16,490
9,260
8,918
3,066
24,483
10,655
Cost of revenues:
Product revenue
1,660
662
2,255
1,250
Service revenue
1,081
527
3,415
2,049
2,741
1,189
5,670
3,299
Gross margin:
Product revenue
1,257
137
5,738
145
Service revenue
4,920
1,740
13,075
7,211
6,177
1,877
18,813
7,356
Operating expenses:
Research and development
56,371
54,043
170,484
146,152
General and administrative
(2)
30,380
20,834
86,241
57,399
Total operating expenses
86,751
74,877
256,725
203,551
Loss from operations
(
80,574
)
(
73,000
)
(
237,912
)
(
196,195
)
Other (expense) income:
Interest expense
(
3,464
)
(
2,908
)
(
9,214
)
(
8,502
)
Interest income
2,628
1,035
7,348
5,740
Loss on issuance of convertible preferred stock
(
355,551
)
—
(
355,551
)
—
Total other (expense)
(
356,387
)
(
1,873
)
(
357,417
)
(
2,762
)
Loss before income taxes
(
436,961
)
(
74,873
)
(
595,329
)
(
198,957
)
Income tax expense
(
253
)
(
191
)
(
580
)
(
246
)
Net loss
(
437,214
)
(
75,064
)
(
595,909
)
(
199,203
)
Convertible preferred stock PIK dividend
(
14,596
)
(
7,035
)
(
39,136
)
(
19,987
)
Net loss attributable to common stockholders
$
(
451,810
)
$
(
82,099
)
$
(
635,045
)
$
(
219,190
)
Net loss per share attributable to common stockholders, basic and diluted
$
(
9.83
)
$
(
1.81
)
$
(
13.86
)
$
(
4.85
)
Weighted average common shares outstanding, basic and diluted
45,948,603
45,269,895
45,807,560
45,174,580
Comprehensive loss:
Net loss
$
(
437,214
)
$
(
75,064
)
$
(
595,909
)
$
(
199,203
)
Foreign currency translation adjustments
(
110
)
23
114
(
47
)
Comprehensive loss
$
(
437,324
)
$
(
75,041
)
$
(
595,795
)
$
(
199,250
)
______________
(1)
Includes related party amounts of $
0
and $
535
(product revenue) and $
1,454
and $
1,260
(service revenue) for the three months ended September 30, 2025 and 2024, respectively. Includes related party amounts of $
0
and $
1,059
(product revenue) and $
5,064
and $
3,805
(service revenue) for the nine months ended September 30, 2025 and 2024, respectively (see Note 14)
.
(2)
Includes related party amounts of $
0
and $(
549
) (general and administrative) for the three months ended September 30, 2025 and 2024, respectively. Includes related party amounts of $(
140
) and $(
1,057
) (general and administrative) for the nine months ended September 30, 2025 and 2024, respectively (see Note 14). See accompanying notes to consolidated financial statements
.
The accompanying notes are an integral part of these condensed consolidated financial statements.
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY
(in thousands, except share and per share amounts)
(unaudited)
Preferred Stock
(Series A, B, C, and C-1)
Common Stock
Including Super Voting
Common Stock and Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Foreign Currency Translation Adjustments
Total Convertible Preferred Stock and Stockholders’ Equity
Shares
(1)
Amount
Shares
(1)
Amount
Balance as of June 30, 2024
81,504,797
$
1,080,447
45,245,488
$
(
5,887
)
$
—
$
(
808,203
)
$
(
83
)
$
266,274
Issuance of common stock for cash
—
—
55,605
—
261
—
—
261
Convertible preferred stock PIK dividend
—
7,035
—
—
(
4,828
)
(
2,207
)
—
—
Stock based compensation
—
—
—
—
4,567
—
—
4,567
Foreign currency translation adjustments
—
—
—
—
—
—
23
23
Net loss
—
—
—
—
—
(
75,064
)
—
(
75,064
)
Balance as of September 30, 2024
81,504,797
$
1,087,482
45,301,093
$
(
5,887
)
$
—
$
(
885,474
)
$
(
60
)
$
196,061
Balance as of June 30, 2025
99,735,577
$
1,438,733
45,895,052
$
(
5,887
)
$
—
$
(
1,139,651
)
$
17
$
293,212
Issuance of common stock for cash
—
—
185,003
—
849
—
—
849
Issuance of convertible Series C preferred stock, net of issuance costs
8,214,452
203,361
—
—
—
—
—
203,361
Issuance of convertible Series C-1 preferred stock, net of issuance costs
23,545,451
724,278
—
—
—
—
—
724,278
Convertible preferred stock PIK dividend
—
14,596
—
—
(
6,362
)
(
8,234
)
—
—
Stock based compensation
—
—
—
—
5,205
—
—
5,205
Warrant expense
—
—
—
—
308
—
—
308
Foreign currency translation adjustments
—
—
—
—
—
(
110
)
(
110
)
Net loss
—
—
—
—
—
(
437,214
)
(
437,214
)
Balance as of September 30, 2025
131,495,480
$
2,380,968
46,080,055
$
(
5,887
)
$
—
$
(
1,585,099
)
$
(
93
)
$
789,889
Balance as of December 31, 2023
81,504,797
$
1,067,495
45,042,081
$
(
5,357
)
$
—
$
(
676,687
)
$
(
13
)
$
385,438
Issuance of common stock for cash
—
—
371,563
—
1,231
—
—
1,231
Repurchase of common stock
—
—
(
112,551
)
(
530
)
—
—
—
(
530
)
Convertible preferred stock PIK dividend
—
19,987
—
—
(
10,403
)
(
9,584
)
—
—
Stock based compensation
—
—
—
—
9,172
—
—
9,172
Foreign currency translation adjustments
—
—
—
—
—
—
(
47
)
(
47
)
Net loss
—
—
—
—
—
(
199,203
)
—
(
199,203
)
Balance as of September 30, 2024
81,504,797
$
1,087,482
45,301,093
$
(
5,887
)
$
—
$
(
885,474
)
$
(
60
)
$
196,061
Balance as of December 31, 2024
99,565,570
$
1,411,313
45,542,122
$
(
5,887
)
$
—
$
(
969,276
)
$
(
207
)
$
435,943
Issuance of common stock for cash
—
—
537,933
—
2,095
—
—
2,095
Issuance of convertible Series C preferred stock, net of issuance costs
8,384,459
206,241
—
—
—
—
—
206,241
Issuance of convertible Series C-1 preferred stock, net of issuance costs
23,545,451
724,278
—
—
—
—
—
724,278
Convertible preferred stock PIK dividend
—
39,136
—
—
(
19,222
)
(
19,914
)
—
—
Stock based compensation
—
—
—
—
16,819
—
—
16,819
Warrant expense
—
—
—
—
308
—
—
308
Foreign currency translation adjustments
—
—
—
—
—
—
114
114
Net loss
—
—
—
—
—
(
595,909
)
—
(
595,909
)
Balance as of September 30, 2025
131,495,480
$
2,380,968
46,080,055
$
(
5,887
)
$
—
$
(
1,585,099
)
$
(
93
)
$
789,889
______________
(1)
Share amounts have been adjusted to reflect the
6.3811681
-for-1 forward stock split that became effective on November 3, 2025 in connection with the initial public offering (see Note 1).
The accompanying notes are an integral part of these condensed consolidated financial statements.
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
16,314
11,313
Loss on disposal of property and equipment
2,473
591
Loss on issuance of convertible preferred stock
355,551
—
Stock based compensation
16,819
9,172
Warrant expense
308
—
Non-cash interest expense
1,508
1,586
Non-cash lease expense
185
330
Changes in operating assets and liabilities:
Accounts receivable
(
5,531
)
(
2,626
)
Prepaid expenses and other current assets
3,653
3,858
Other assets and liabilities
(
6
)
19
Accounts payable, accrued expenses and current liabilities
17,990
7,564
Operating lease liabilities
(
27
)
(
226
)
Deferred revenue
3,286
2,360
Net cash used in operating activities
(
183,386
)
(
165,262
)
Investing activities
Purchases of property and equipment
(
25,663
)
(
51,681
)
Proceeds from sale of property and equipment
1,296
380
Net cash used in investing activities
(
24,367
)
(
51,301
)
Financing activities
Proceeds from convertible Series C preferred stock
150,406
—
Proceeds from convertible Series C-1 preferred stock
422,375
—
Proceeds from sale-leaseback transaction
32,658
—
Proceeds from the issuance of promissory note
—
15,501
Payment of debt issuance costs
—
(
150
)
Repayment of borrowings
(
2,103
)
(
685
)
Issuance of common stock
2,095
1,231
Principal payments on finance lease obligations
(
46
)
(
39
)
Stock issuance costs
(
7,005
)
—
Repurchase of common stock
—
(
530
)
Net cash provided by financing activities
598,380
15,328
Effect of currency translation on cash, cash equivalents and restricted cash
(
20
)
(
24
)
Increase (decrease) in cash, cash equivalents and restricted cash
390,607
(
201,259
)
Cash, cash equivalents and restricted cash at beginning of period
302,025
254,136
Cash, cash equivalents and restricted cash at end of period
$
692,632
$
52,877
Supplemental disclosure of cash flow information
Cash paid for interest
7,946
6,842
Cash paid for taxes
117
34
Non-cash investing and financing activities
Right-of-use assets recognized for new leases
1,243
796
Right-of-use assets modified for amendments
6
(
1,138
)
Property and equipment recorded in accounts payable
4,147
12,319
Stock issuance costs recorded in accounts payable and accrued liabilities
1,773
1,405
Deferred offering costs included in accounts payable and accrued expenses and other liabilities
6,181
—
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the condensed consolidated balance sheet to the total of the amounts in the consolidated statements of cash flows (in thousands):
As of
September 30, 2025
As of
September 30, 2024
Cash and cash equivalents
$
687,627
$
52,248
Restricted cash included in:
Prepaid expenses and other current assets
4,561
147
Other assets
444
482
Total cash, cash equivalents and restricted cash in the condensed statements of cash flows
$
692,632
$
52,877
The accompanying notes are an integral part of these condensed consolidated financial statements.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(in thousands, except share and per share amounts)
(unaudited)
1.
NATURE OF OPERATIONS AND LIQUIDITY
BETA Technologies, Inc. (“BETA” or the “Company”) designs, manufactures, and sells high-performance electric aircraft, advanced electric propulsion systems, charging systems and components. The Company specializes in the design, development, and manufacturing of electric aircraft, including advanced flight control and electric propulsion systems, with a focus on clean aviation technology. In addition, the Company manufactures and operates charge stations and infrastructure for charging electric aircraft. The charging systems provide the power needed to safely, quickly, and efficiently charge electric aircraft. The Company also maintains and provides access to simulators for its customers and partners to understand the capabilities of the aircraft.
On November 5, 2025, the Company completed its initial public offering (the “IPO”) of
34,330,882
shares of the Company’s Class A common stock at a price to the public of $
34.00
per share,
inclusive of the exercise in full by the underwriters to purchase from the Company
4,477,941
shares of Class A common stock
. The Company received net proceeds from the IPO of approximately $
1,103,327
, after deducting approximately $
63,922
in underwriting discounts and commissions. The Company’s Class A common stock trades on the New York Stock Exchange under the symbol “BETA.”
In connection with the IPO, all shares of the Company’s pre-IPO convertible preferred stock (“Preferred Stock”), including the acceleration of the related paid-in-kind (“PIK”) dividend, automatically converted into
147,806,862
shares of the Company’s pre-IPO common stock. In addition, the Company authorized a
6.3811681
-for-1 forward stock split of the Company’s pre-IPO common stock and pre-IPO super voting common stock (the “Stock Split”) and the reclassification and exchange of the resulting stock into Class A common stock and Class B common stock. Following the IPO,
no
shares of Preferred Stock remained outstanding. All references in these consolidated financial statements to shares, share prices, exercise prices, and other per share information in all periods have been adjusted, on a retroactive basis, to reflect the Stock Split.
2.
BASIS OF PRESENTATION AND ACCOUNTING POLICIES
Basis of Presentation and Principles of Consolidation
The accompanying unaudited condensed consolidated financial statements included have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial reporting and as required by Form 10-Q. These condensed consolidated financial statements are unaudited and, in the opinion of management, reflect all normal recurring adjustments necessary to fairly present the financial position, results of operations, cash flows, and change in equity for the periods presented. Results for the periods presented are not necessarily indicative of the results that may be expected for any subsequent period. These unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes as of and for the year ended December 31, 2024 included in the Prospectus. Any reference in these notes to applicable guidance is meant to refer to the authoritative United States generally accepted accounting principles as found in the Accounting Standards Codification (the “ASC”) and Accounting Standards Updates (“ASU”) of the Financial Accounting Standards Board (the “FASB”).
The Company’s condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
The Company is an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that it (i) is no longer an emerging growth company or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. The Company expects to use the extended transition period for any other new or revised accounting standards during the period in which it remains an emerging growth company.
Summary of Significant Accounting Policies
There have been no other changes to the Company’s significant accounting policies described in Note 2 “Summary of Significant Accounting Policies” to the consolidated financial statements and notes as of and for the year ended December 31, 2024 included in the Prospectus that have had a material impact on the condensed consolidated financial statements and related notes, other than those described below. Certain items in the prior year’s audited consolidated financial statements have been reclassified to conform to the current presentation.
Concentration of Credit Risk
Specific revenue from customers exceeding 10% of total revenues for the three and nine months ended September 30, 2025 and 2024 were as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025
2024
2025
2024
Customer A
*
21
%
21
%
43
%
Customer B
16
%
41
%
18
%
35
%
Customer C
*
17
%
*
11
%
Customer D
*
*
15
%
*
Customer E
26
%
*
*
*
Customer F
15
%
*
*
*
Customer G
23
%
*
*
*
______________
*
Less than 10%
Specific customer receivable balances in excess of 10% of total accounts receivable as of September 30, 2025 and December 31, 2024 were as follows:
The Company capitalizes certain legal, professional accounting, and other third-party fees that are directly associated with in-process equity financings as deferred offering costs until such financings are consummated. After consummation of the equity financing, these costs are recorded as a reduction of the proceeds from the offering, either as a reduction of the carrying value of the Preferred Stock or in stockholders’ equity as a reduction of additional paid-in-capital generated as a result of the offering.
The Company recorded $
6,724
of deferred offering costs as of September 30, 2025 and there were
no
deferred offering costs as of December 31, 2024. As a result of the IPO, the Company recorded a reduction of the carrying value of the Class A common stock of $
10,723
in November 2025.
Loss on Issuance of Convertible Preferred Stock
As of the closings of Series C and Series C-1 Preferred Stock issued during the three months ended September 2025, the estimated fair value of the Preferred Stock ranged between $
114.47
and $
196.73
per share compared with the purchase price per share of $
114.47
. As a result, the Company recorded a non-cash loss of $
355,551
to other expense to account for the difference between the amount of aggregate purchase price and the fair value of the shares issued as of the date of issuance. The estimated fair value of the Preferred Stock was prepared using the hybrid method, with one or more scenarios using the option pricing model (the “OPM”) to allocate the equity value to respective share classes. The valuation was based on numerous valuation factors, including, but not limited to economic factors, industry trends, and likelihood of achieving a liquidity event. These are level 3 inputs within the fair value hierarchy and require significant judgment or estimation.
Collaboration Agreements
The Company assesses joint development arrangements to determine whether they are in the scope of ASC 808 – Collaborative Arrangements (“ASC 808”). The Company evaluates whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on commercial success of the activities. This assessment is performed throughout the life of such arrangement with consideration given to the changes in the roles and responsibilities between the parties.
On September 3, 2025, the Company entered into a Strategic Collaboration Agreement and Joint Technology Development Agreement (together, the “GE Collaboration Agreements”) with General Electric Company, operating as GE Aerospace (“GE Aerospace”) within the scope of ASC 808 to research, develop, manufacture, test, market, sell, field, and support propulsion technologies for hybrid-electric applications, including turbogenerators for future sales to the commercial civilian aircraft market and government customers. Both parties provide engineering personnel, technical expertise, commercial resources, and support to carry out commitments under the GE Collaboration Agreements and are exposed to significant risks as both parties are responsible for its own costs during the development period. Furthermore, both parties participate on a joint development committee that directs the parties’ collaboration across aspects of development. Costs BETA incurs in connection with the GE Collaboration Agreements are recorded within research and development expense.
In connection with the GE Collaboration Agreements, on September 26, 2025, the Company issued warrants to purchase
2,552,467
shares of Class A common stock to GE Aerospace at a pre-split exercise price of $
0.01
per share (the “GE Warrants”). The GE Warrants are exercisable upon vesting, and vest subject to the satisfaction of certain milestones, with any shares that remain unvested on the third anniversary of September 3, 2025 vesting on such date if the Company and GE Aerospace are continuing to work together under the GE Collaboration Agreements (or similar arrangements) as of such date. The aggregate grant date fair value of the warrants was $
67,236
. The estimated fair value of the common stock was prepared using the hybrid method, with one or more scenarios using the OPM to allocate the equity value to the GE Warrants. The valuation was based on numerous valuation factors, including, but not limited to economic factors, industry trends, and likelihood of achieving a liquidity event. These are level 3 inputs within the fair value hierarchy and require significant judgment or estimation. The Company recorded research and development expense of $
308
related to the GE Warrants as of September 30, 2025.
In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures. ASU 2023-09 requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The new standard is effective for annual periods beginning after December 15, 2025, with early adoption permitted. The guidance will be applied on a prospective basis with the option to apply the standard retrospectively. The Company is still evaluating the effects of adopting this accounting standard on the condensed consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income -Expense Disaggregation Disclosures (subtopic 220-40): Disaggregation of Income Statement Expenses, which requires public entities to disclose in the notes to the consolidated financial statements, of specified information about certain costs and expenses. In January 2025, the FASB issued ASU 2025-01, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (subtopic 220-40): Disaggregation of Income Statement Expenses, Clarifying the Effective Date. ASU 2025-01 clarifies that the guidance in ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is still evaluating the effects of adopting this accounting standard on the condensed consolidated financial statements.
3.
REVENUE RECOGNITION
Disaggregated Revenue
The Company disaggregates revenue from contracts with customers by customer type, product, or service type, and geographic location, as the Company believes these categories best depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors.
The Company’s revenues for customer type are as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025
2024
2025
2024
U.S. Government
$
2,702
$
892
$
7,674
$
5,271
Commercial customers
6,216
2,174
16,809
5,384
Total
$
8,918
$
3,066
$
24,483
$
10,655
The Company’s revenues for product or service type are as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025
2024
2025
2024
Product revenue
$
2,917
$
799
$
7,993
$
1,395
Service revenue
6,001
2,267
16,490
9,260
Total
$
8,918
$
3,066
$
24,483
$
10,655
The Company’s revenue was derived from sales to customers in the United States for the three months ended September 30, 2025 and
2024
of $
8,667
and $
3,066
and the nine months ended September 30, 2025 and 2024 of $
24,232
and $
10,655
, respectively.
The Company generated $
251
of revenue from international customers for the three and nine months ended
September 30, 2025
and there was
no
revenue generated from international customers for the three and nine months ended September 30, 2024.
The following table provides information about contract liabilities from contracts with customers (in thousands):
As of
September 30,
2025
As of
December 31,
2024
Contract liabilities, current
$
(
3,616
)
$
(
6,401
)
Contract liabilities, non-current
(
12,430
)
(
6,360
)
Total
$
(
16,046
)
$
(
12,761
)
Contract liabilities increased during the nine months ended September 30, 2025, primarily due to payments received in excess of revenue recognized on performance obligations. During the nine months ended September 30, 2025 and 2024, the Company recognized $
5,854
and $
453
of our contract liabilities as of December 31, 2024 and December 31, 2023, respectively, as revenue. Contract liabilities, current includes $
1,000
of customer deposits as of September 30, 2025 and
no
customer deposits as of December 31, 2024. Contract liabilities, non-current includes $
3,885
and $
2,660
of customer deposits as of September 30, 2025 and December 31, 2024, respectively. During the three and nine months ended September 30, 2025 and
2024
, the Company also entered into agreements for aircraft sales pre- and post-certification, with options for pre-certified aircraft that have not been executed. These agreements have
no
associated revenues or cost of sales for the three and nine months ended September 30, 2025 and
2024
.
Remaining Performance Obligations
Remaining performance obligations represent the amount of contracted future revenue that has not yet been recognized. As of September 30, 2025, the Company’s remaining performance obligations were $
18,679
. The Company currently expects to recognize approximately $
10,058
of the remaining performance obligations as revenue over the next
12
months and the remaining to be recognized thereafter.
4.
PROPERTY AND EQUIPMENT, NET
Property and equipment, net consisted of the following (in thousands):
As of
September 30,
2025
As of
December 31,
2024
Computer equipment and software
$
12,518
$
12,194
Furniture and fixtures
1,643
1,615
Machinery and equipment
97,307
78,024
Vehicles and aviation
17,635
15,546
Recharge sites
18,003
12,045
Leasehold improvements
27,484
25,888
Buildings and structures
189,144
182,058
Land improvements
1,239
1,239
Land
2,232
593
Construction in progress
13,236
22,914
Total property and equipment
380,441
352,116
Less: accumulated depreciation
48,735
32,528
Property and equipment, net
$
331,706
$
319,588
Depreciation expense for the three months ended September 30, 2025 and 2024 was $
5,794
and $
3,888
, respectively. Depreciation expense for the nine months ended September 30, 2025 and 2024 was $
16,314
and $
11,313
, respectively.
As of September 30, 2025 and December 31, 2024, the Company had assets held for sale of $
0
and $
852
included within prepaid expenses and other current assets, respectively. During the three months ended September 30, 2025 and 2024, the Company disposed $
1,296
and $
352
of property and equipment, net, respectively. During the nine months ended September 30, 2025 and 2024, the Company disposed $
3,769
and $
971
of property and equipment, net, respectively.
5.
NOTES PAYABLE
On December 13, 2023, the Company entered into a credit agreement with the Export-Import Bank of the United States (“Ex-Im”) (such agreement, the “Ex-Im Credit Agreement”). The Ex-Im Credit Agreement provides a $
170,103
direct loan facility (the “Ex-Im Credit Facility”), which the Company drew $
170,103
as of September 30, 2025 and December 31, 2024. Of the $
170,103
in principal amount of borrowings made under the Ex-Im Credit Agreement, $
151,250
can be used to finance the costs of construction of the Company’s production facility, with the remaining $
18,853
, or
12.46
% of borrowings, used to finance the total exposure fees incurred under the agreement. The discount of $
20,207
as of December 31, 2024 consists of the initial exposure fee and debt issuance costs. As of September 30, 2025 and December 31, 2024, exposure fees were $
18,853
and debt issuance costs were $
1,354
, which are amortized to interest expense on an effective interest rate basis over the term of the Ex-Im Credit Agreement.
Borrowings under the Ex-Im Credit Agreement bear interest at a fixed rate per annum of
5.52
%, payable quarterly in arrears. The effective per annum interest rate on the Company’s outstanding borrowings under the Ex-Im Credit Agreement, which takes into account timing and amount of borrowings and payments, exposure fees, and debt issuance costs, is
7.32
%. Borrowings under the Ex-Im Credit Agreement are required to be repaid in
54
quarterly installments, commencing on September 20, 2025, with a maturity date of December 20, 2038. The Ex-Im Credit Agreement is secured by first-priority liens on the production facility of our aircraft manufacturing campus located in South Burlington, Vermont (the “Final Assembly Facility”).
In addition, the Ex-Im Credit Agreement contains covenants that limit, among other things, the Company’s ability to sell assets, participate in mergers and acquisitions, and grant liens on certain assets.
As of September 30, 2025, the Company recognized $
32,505
in notes payable, non-current, as a result of a sale-leaseback transaction. S
ee Note 6 “Leases”.
Notes payable consisted of the following (in thousands):
As of
September 30,
2025
As of
December 31,
2024
Ex-Im credit agreement
$
168,685
$
170,103
Unamortized discount and debt issuance costs
(
16,417
)
(
18,037
)
Financing liability
32,505
—
Total notes payable
184,773
152,066
Less: notes payable, current
(
5,670
)
(
2,835
)
Notes payable, non-current
$
179,103
$
149,231
The Company’s Ex-Im Credit Agreement is recorded on an amortized cost basis and has a fair value of $
153,913
and $
157,043
as of September 30, 2025 and December 31, 2024, respectively. The fair value of the Ex-Im Credit Agreement is based on quoted prices in similar markets, which is a Level 2 input within the fair value hierarchy.
6.
LEASES
The Company’s lease arrangements consist of facility, vehicle, aircraft, and equipment leases, as well as other short-term leases for storage and office space.
In July 2025, the Company entered into a sale-leaseback transaction with a related party for
two
of its buildings with an initial leaseback term of
29
years. The sale-leaseback transaction was evaluated under the sale and leaseback guidance in ASC 842-40, Leases – Sale and Leaseback Transactions. Due to the Company obtaining the ability to direct the use of and substantially all the benefits from the underlying assets, the transaction was accounted for as a debt financing. As a result, the Company continues to reflect the building in property and equipment, net, as if it were the legal owner, and continues to recognize depreciation expense over its estimated useful life. In July 2025, the Company recorded an initial financing liability of $
32,658
, net of transaction costs. As of September 30, 2025, the Company recognized $
32,505
in notes payable, non-current. The Company will not recognize rent expense related to the leased assets. Instead, monthly rent payments are recorded as interest expense and a reduction of the outstanding liability. For the three and nine months ended September 30, 2025, payments of $
701
representing interest expense were made under the financing.
There have been no other material changes to the Company’s leases during the three and nine months ended September 30, 2025.
7.
COMMITMENTS AND CONTINGENCIES
Commitments
On May 25, 2021, the Company exercised its right to buy shares back from a former employee of the Company, to be paid over
five years
. In accordance with the fair value of the shares determined by the Company, as of September 30, 2025 and December 31, 2024, the Company’s remaining liability for the share buy-back was $
228
and $
913
, respectively.
Legal Proceedings
At each reporting date, the Company evaluates whether a potential loss amount or a potential range of loss is probable and reasonably estimable under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company expenses as incurred the costs related to its legal proceedings. As of September 30, 2025, the Company was not aware of any material existing, pending, or threatened legal actions against the Company.
Indemnification Agreements
As permitted under Delaware law, the Company indemnifies its officers, directors, and employees for certain events or occurrences while the officer or director is, or was, serving at the Company’s request in such capacity. The term of the indemnification is for the officer’s or director’s lifetime. Further, in the ordinary course of business, the Company may provide indemnification of varying scope and terms to vendors, lessors, business partners, and other parties with respect to certain matters including, but not limited to, losses arising out of breach of such agreements or from intellectual property infringement claims made by third parties. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is, in many cases, unlimited. To date however, the Company has not incurred any material costs as a result of such indemnifications nor experienced any losses related to them. As of September 30, 2025, the Company was not aware of any claims under indemnification arrangements and does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible; therefore, no related reserves were established.
8.
CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY
Common Stock
As of September 30, 2025 and December 31, 2024, the Company had
239,813,390
and
223,340,884
shares of common stock authorized and
37,578,571
and
37,040,639
shares of common stock issued and outstanding, respectively. Each holder of the Company’s common stock is entitled to
one
vote for each share on all matters submitted to a vote of the stockholders, including the election of directors.
13
Super Voting Common Stock
During 2021, the Company authorized and issued
8,501,484
shares of super voting common stock, which remained outstanding as of September 30, 2025. The holder of the Company’s super voting common stock, the Company’s Chief Executive Officer, is entitled to
forty
votes for each share on all matters submitted to a vote of the stockholders, including the election of directors. Each share of super voting common stock is convertible into
one
share of common stock at any time.
The size of the board of directors cannot be changed without the consent of the individual owning the shares of super voting common stock. The individual also retains the right to designate a majority of the board. As of September 30, 2025,
two
board members are designated by specific holders of the Preferred Stock. The election of the remaining minority board members is submitted to a vote of the stockholders.
Preferred Stock
The Company’s certificate of incorporation, as amended, designates and authorizes the Company to issue
141,365,814
shares of Preferred Stock, of which
32,039,539
shares are designated as Series A Preferred Stock,
3,064,920
shares are designated as Series A-1 Preferred Stock,
10,110,916
shares are designated as Series A-2 Preferred Stock,
10,873,242
shares are designated as Series A-3 Preferred Stock,
30,925,502
shares are designated as Series B Preferred Stock,
26,479,034
shares are designated as Series C Preferred Stock and
27,872,661
are designated as Series C-1 Preferred Stock.
For the three months ended September 30, 2025, the Company issued
3,978,505
shares of previously authorized Series C Preferred Stock and expanded the shares authorized and issued pursuant to the Series C Preferred Stock offering by
4,235,947
shares that provided aggregate net proceeds of $
147,357
. The participants of the Series C Preferred Stock offering consisted of new and previous investors, including board members and their associated companies, and certain members of management.
In September 2025, the Company entered into a Series C-1 Preferred Stock purchase agreement. Through September 30, 2025, the Company issued
16,723,599
shares of Series C-1 Preferred Stock to GE Aerospace for total proceeds of $
300,000
. The Company issued an additional
6,821,852
shares of Series C-1 Preferred Stock for aggregate net proceeds of $
122,375
to new and previous investors, including board members and their associated companies.
For the three months ended September 30, 2025, the Company declared a PIK dividend for the Series B, Series C, and Series C-1 Preferred Stock of $
7,467
, $
6,661
, and $
468
, respectively. For the three months ended September 30, 2024, the Company declared a PIK dividend for the Series B Preferred Stock of $
7,035
.
For the nine months ended September 30, 2025, the Company declared a PIK dividend for the Series B, Series C, and Series C-1 Preferred Stock of $
22,071
, $
16,597
, and $
468
, respectively. For the nine months ended September 30, 2024, the Company declared a PIK dividend for the Series B Preferred Stock of $
19,987
.
The amounts of stock based compensation expense recorded is as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025
2024
2025
2024
Cost of product revenue
$
37
$
11
$
67
$
11
Cost of service revenue
38
30
119
90
Research and development
2,051
1,802
5,877
4,021
General and administrative
3,079
2,724
10,756
5,050
Total stock based compensation
$
5,205
$
4,567
$
16,819
$
9,172
During the nine months ended September 30, 2025, the Company approved modifications to certain incentive stock option awards in connection with the termination of service of an employee. These modifications resulted in an extension of the post-termination exercise period for vested awards and a change of vesting conditions for unvested awards. As a result of these modifications, the Company recorded additional stock based compensation of $
3,799
during the nine months ended September 30, 2025.
As of September 30, 2025 and December 31, 2024, the total number of shares of common stock that may be issued under the 2018 Plan was
25,084,129
, of which
1,298,491
and
4,598,168
, respectively, remained available for future grant.
10.
INCOME TAXES
During the three months ended September 30, 2025 and 2024, the Company recorded $
253
and $
191
of tax expense. During the nine months ended September 30, 2025 and 2024, the Company recorded $
580
and $
246
of tax expense. For the three and nine months ended September 30, 2025 and 2024, the provision for income taxes differed from the United States federal statutory rate primarily due to the change in jurisdictional mix of earnings.
11.
NET LOSS PER SHARE
Net loss per share basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025
2024
2025
2024
Numerator:
Net loss
$
(
437,214
)
$
(
75,064
)
$
(
595,909
)
$
(
199,203
)
Preferred Stock PIK dividend
(
14,596
)
(
7,035
)
(
39,136
)
(
19,987
)
Net loss attributable to common stockholders
$
(
451,810
)
$
(
82,099
)
$
(
635,045
)
$
(
219,190
)
Denominator:
Weighted average common shares outstanding, basic and diluted
45,948,603
45,269,895
45,807,560
45,174,580
Net loss per share, basic and diluted
$
(
9.83
)
$
(
1.81
)
$
(
13.86
)
$
(
4.85
)
As of September 30, 2025, the Company’s Series B, Series C, and Series C-1 preferred stockholders were entitled to cumulative dividends based on their stated value. As such, the Company calculates its net loss attributable to common stockholders by adjusting its net loss for the aggregate cumulative dividends that had accrued since the original issuance dates in the period in which the preferred stockholders became legally entitled to such dividends.
The Company’s potentially dilutive securities, which include preferred stock, warrants and stock options, have been excluded from the computation of diluted net loss per share as the effect would be anti-dilutive. Therefore, the weighted average number of common shares outstanding used to calculate both basic and diluted net loss per share attributable to common stockholders is the same.
The following potentially dilutive securities have been excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:
Nine Months Ended
September 30,
2025
2024
Series A Preferred Stock
56,088,617
56,088,617
Series B Preferred Stock
25,416,180
25,416,180
Series C Preferred Stock
26,445,232
—
Series C-1 Preferred Stock
23,545,451
—
Warrants to purchase common stock
2,552,467
—
Options to purchase common stock
20,235,533
17,805,533
154,283,480
99,310,330
12.
SEGMENT REPORTING
The Company has
one
operating and reportable segment – Development and Manufacturing Electric Aircrafts. The Company determined its reportable segment using the management approach based on how the chief operating decision maker (the “CODM”) evaluates the business. Substantially all Company’s fixed assets are located in the United States and all of the Company’s revenue is generated in the United States. The Company’s foreign operations consist of expenses associated with engineering and related supporting administrative services.
The Company’s CODM is its Chief Executive Officer. As the Company has a single reportable segment and is managed on a consolidated basis, the measure of segment profit or loss is consolidated net loss as reported in the consolidated statements of operations and comprehensive loss. The CODM reviews the financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and evaluating financial performance. The CODM does not use any segment asset measures to assess performance and decide how to allocate resources. The Company does not have intra-entity sales or transfers.
The Company’s reportable segment information is as follows (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025
2024
2025
2024
Revenues
$
8,918
$
3,066
$
24,483
$
10,655
Cost of revenues
2,741
1,189
5,670
3,299
Operating and other expenses
Research and development
56,371
54,043
170,484
146,152
General and administrative
30,380
20,834
86,241
57,399
Other segment items
(1)
356,640
2,064
357,997
3,008
Net loss
$
(
437,214
)
$
(
75,064
)
$
(
595,909
)
$
(
199,203
)
______________
(1)
Other segment items are comprised of the loss on issuance of convertible preferred stock, interest income/expense and income taxes.
As a result of government assistance received under the Company’s agreements with
Advanced Regenerative Manufacturing Institute, Inc. (“
ARMI”) and Michigan Department of Transportation, incorporated by reference to “2023 Agreement,” “2024 Agreement,” and “MDOT” in the Prospectus, the Company recorded reductions within the following accounts for proceeds received from government assistance programs (in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025
2024
2025
2024
General and administrative expenses
$
—
$
549
$
140
$
1,057
Research and development expenses
352
327
1,001
691
Property and equipment
1,190
1,522
1,888
2,640
14.
RELATED PARTY TRANSACTIONS
The Company generates revenues and expenses from transactions with related parties, primarily through the Company’s relationship with United Therapeutics Corporation, ARMI, and GE Aerospace, who have executives that are also on the Company’s Board of Directors. These amounts are disclosed within the Company’s unaudited condensed consolidated balance sheets and condensed consolidated statements of operations and comprehensive loss.
Additionally, the Company enters into certain transactions with members of management for the lease of aircraft and property for use within the business. The aggregate expenses are not material and are included with general and administrative expenses for the three and nine months ended September 30, 2025 and 2024, respectively.
Sale-Leaseback Transaction
In July 2025, the Company entered into a sale-leaseback transaction for
two
of its buildings with an associated company of a board member. The Company received $
32,658
in net proceeds from the sale with an initial leaseback term of
29
years. See Note 6 “Leases” for additional information on the sale-leaseback transaction.
Series C Financing
During the three months ended September 30, 2025, as part of the Series C financing,
5,397,160
shares of Series C Preferred Stock were purchased by certain of the Company’s directors, their associated companies, and certain members of management. During the nine months ended September 30, 2025, as part of the Series C financing,
5,388,801
shares of Series C Preferred Stock were purchased by certain of the Company’s directors, their associated companies, and certain members of management.
Series C-1 Financing
During the three and nine months ended September 30, 2025, as part of the Series C-1 financing,
668,261
shares of Series C-1 Preferred Stock were purchased by certain of the Company’s board members and their associated companies, exclusive of GE Aerospace.
On September 3, 2025, the Company entered into a Series C-1 Preferred Stock purchase agreement. On September 26, 2025, the Company issued
16,723,599
shares of Series C-1 Preferred Stock to GE Aerospace for total proceeds of $
300,000
in connection with the initial closing of the Series C-1 Preferred Stock financing. The Company recorded a non-cash loss on the issuance of Preferred Stock of $
215,585
in connection with this transaction during the three and nine months ended September 30, 2025. As a result of the transaction, GE Aerospace received the right to designate
one
member to the Company’s Board. Additionally, on September 3, 2025, the Company entered into the GE Collaboration Agreements to advance hybrid-electric propulsion for next-generation aircraft for a term of
10
years. In connection with these agreements, on September 26, 2025, the Company issued warrants to GE Aerospace to purchase
2,552,467
shares of the Company’s Class A common stock. The GE Warrants are exercisable upon vesting, and vest subject to the satisfaction of certain milestones, with any warrants that remain unvested on the third anniversary of September 3, 2025 become vested on such date if the Company and GE Aerospace are continuing to work together under the GE Collaboration Agreements (or a similar arrangement). The Company recorded research and development expense of $
308
in connection with the GE Collaboration Agreements during the three and nine months ended September 30, 2025.
15.
PREPAID EXPENSES AND OTHER CURRENT ASSETS
Prepaid expenses and other current assets consist of the following (in thousands):
As of
September 30,
2025
As of
December 31,
2024
Restricted cash
$
4,561
$
149
Prepaid expenses
6,488
6,408
U.S. Grants receivable
—
9,897
Supplies and materials
2,790
3,659
Assets held for sale
—
852
Other
3,357
2,826
Prepaid expenses and other current assets
$
17,196
$
23,791
16.
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
Accrued expenses and other current liabilities consist of the following (in thousands):
Subsequent to September 30, 2025, the Company issued
1,866,989
shares of the Series C-1 Preferred Stock offering that provided aggregate net proceeds of $
33,491
from an entity affiliated with one of the Company’s board members. In connection with the issuance, the Company recorded a loss on the issuance of Preferred Stock of $
24,067
as a result of the difference between the estimated fair value of the Series C-1 Preferred Stock as of the closing date and the purchase price per share.
On October 15, 2025, following the approval of the stockholders of the Company, and effective upon the consummation of the IPO, the Board adopted the BETA Technologies Omnibus Incentive Plan (the “2025 Plan”). The 2025 Plan provides for grants of (i) stock options, (ii) stock appreciation rights, (iii) restricted shares, (iv) performance awards, (v) other share-based awards and (vi) other cash-based awards to eligible employees, non-employee directors and consultants of the Company. The initial number of shares of common stock reserved for issuance under the 2025 Plan is
36,207,812
shares of Class A common stock. The total number of shares reserved for issuance under the 2025 Plan increases on January 1 of each of the first 10 calendar years during the term of the 2025 Plan by the lesser of: (i) a number of shares of our common stock equal to
5
% of the total number of shares of the Company’s Class A common stock outstanding on December 31 of the preceding calendar year or (ii) a lesser number of shares of the Company’s Class A common stock as determined by the Board.
On October 15, 2025, following the approval of the stockholders of the Company, and effective upon the consummation of the IPO, the Board adopted the BETA Technologies, Inc. 2025 Employee Stock Purchase Plan (the “2025 ESPP”). The initial number of shares of Class A common stock which will be authorized for sale under the 2025 ESPP is
2,413,854
shares of Class A common stock. The 2025 ESPP is expected to be implemented during 2026.
On November 5, 2025, the Company completed its IPO of
34,330,882
shares of the Company’s Class A common stock at a price to the public of $
34.00
per share for net proceeds of $
1,103,327
after deducting underwriting discounts and commissions payable by the Company. See Note 1 “Nature of Operations and Liquidity”.
In addition, effective November 7, 2025, the Company’s Board granted awards of restricted stock units under the 2025 Plan to certain of the Company’s employees, contractors and advisors, representing an aggregate of approximately
1,640,769
shares of Class A common stock underlying the awards.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and related notes, and other financial information, included elsewhere in this Quarterly Report on Form 10-Q and our Prospectus filed with the SEC on November 4, 2025 in connection with our IPO. As discussed in the section titled “Special Note Regarding Forward-Looking Statements,” the following discussion contains forward-looking statements reflecting our current expectations, estimates and assumptions concerning events and financial trends that may affect our future operating results or financial position. Actual results and the timing of events may differ materially from those contained in these forward-looking statements due to a number of factors. Factors that could cause or contribute to such differences include, but are not limited to, capital expenditures, economic and competitive conditions, regulatory changes and other uncertainties, including those discussed below and in the section titled “Risk Factors” included under Part II, Item 1A below, as well as in the Prospectus, all of which are difficult to predict. In light of these risks, uncertainties and assumptions, the forward-looking events discussed may not occur. We assume no obligation to update any of these forward-looking statements. Unless otherwise indicated or in the context otherwise requires, all references in this section to the “Company,” “BETA,” “we,” “us” or “our” refer to BETA Technologies, Inc. and its consolidated subsidiaries.
Overview
We
are
redefining
the
aerospace
industry.
We have developed
an electric
aircraft
platform
and propulsion systems
that
are
positioned
to
transform
the
aviation
industry
forward
into
a new phase
of growth. We design, manufacture,
and sell
high-performance
electric
aircraft,
advanced
electric
propulsion systems,
charging systems, and components.
Further,
we have invested
in the
underlying
infrastructure
of this
breakthrough
technology, which
is
critical
to
bringing
electric
aviation
to life.
We believe
we have developed
a differentiated
presence
in North America
and are
well
positioned
to expand globally.
Our
company
was
purpose-built
to capture
the
significant,
untapped
market
opportunity
in sustainable, reliable
and efficient
electric
aviation.
Vertical
integration
allows
us to innovate
rapidly
and capture
meaningful
economic
value
throughout
an aircraft’s
lifetime,
by
providing
batteries
and
aftermarket
services
for
BETA aircraft
and other
customers.
Our focus
is
on the
e
nabling
t
echnologies
essential
to electric
aviation,
including motors, inverters, batteries,
flight
controls, charging systems, and
a
nationwide electric charging network (“Enabling Technologies”).
With
proprietary
control
over these
core
technologies,
we
offer
customers
a complete
platform
to support
their
adoption
of electric
aircraft
to enable
both
existing
and
new
missions.
This multilayered
approach
provides
us with recurring,
high margin opportunities.
We
are
developing
highly
scalable
technologies
that
can be tailored
to and deployed
for
cost-effective
and safe
missions
across
cargo
and
logistics,
medical,
defense
and
passenger
end
markets.
Our simplified
approach
to designing
electric
aircraft
allows
us
to
service
a
variety
of
end
markets
and
mission
types
leveraging
the
same core
technologies.
The portability
of our technologies
and systems
across
various
aircraft
also
unlocks
flexibility to innovate
on future
generations
of aircraft.
Recent Developments
On November 5, 2025, we completed our IPO, in which we issued and sold an aggregate of
34,330,882
shares of our Class A common stock at a price to the public of
$34.00
per share, inclusive of the exercise in full by the underwriters to purchase from the Company
4,477,941
shares of Class A common stock. We received net proceeds from the IPO of approximately
$1,103
million after deducting the underwriting discounts and commissions payable by us.
On October 15, 2025, we completed an additional sale and issuance of 1,866,989 shares of our Series C-1 Preferred Stock to an entity affiliated with a board member of the Company, for proceeds of $33.5 million.
Components of Results
of Operations
We
use
a
variety
of
financial
metrics
to
assess
the
performance
of
our
operations,
including:
revenues;
cost of revenues;
research
and development
expenses;
and general
and administrative
expenses.
Our
product
revenue
is
primarily
generated
from
the
sale
of
tangible
products
such
as
ground support equipment (“
GSE”) and
Enabling Technologies for our aircraft
.
Our service
revenue
is
primarily
generated
from engineering,
consulting
and other
service
arrangements
for
our customers.
Service
revenue
also
includes
revenue
associated
with usage
and priority
access
from
our charge
stations.
Costs of Revenues
Cost
of product
revenues
and service revenues may include the direct cost of
materials, labor, subcontractors,
depreciation,
and
overhead
costs
(where
allowable)
depending
on
the
nature
of
the
agreement. Included
within
cost
of product
revenues
are
purchases made directly
for contractual
performance
obligations primarily
recognized
over
time,
and as such no inventories
are
recorded
in the
consolidated
balance
sheet.
Research and Development
Expenses
We
have
invested
in
research
and
development
for
our electric
aircraft,
electric
propulsion
systems
and charging
solutions
and network.
We have also
invested
in critical
components
of our enabling technology including
batteries,
motors
and
flight
computers.
We manage
our expenses
based
on several
factors,
including industry
conditions
and expected
demand
for
our services.
Researc
h
an
d
developmen
t
expense
s
consis
t
primaril
y
o
f
personne
l
expenses
,
includin
g
salaries
,
benefits
,
and stoc
k
base
d
compensation
,
expense related to the GE Warrants,
cost
s
o
f
consulting
,
equipmen
t
an
d
materials
,
temporar
y
tooling
,
depreciatio
n
and amortizatio
n
associate
d
wit
h
long-live
d
assets
,
an
d
certai
n
overhea
d
expenses
,
includin
g
rent
,
information technolog
y
cost
s
an
d
utilities
.
Researc
h
an
d
developmen
t
expense
s
ar
e
partiall
y
offse
t
b
y
ta
x
credit
s
fo
r
scientific researc
h
an
d
developmen
t
fro
m the Revenue Authority of Canada and Revenu Québec, the provincial revenue authority of the C
anadia
n
provinc
e
o
f
Québec,
an
d
payment
s
w
e
receiv
e
i
n
th
e
for
m
o
f
governmen
t
grants.
General and Administrative
Expenses
General
and
administrative
expenses
consist
of
personnel
expenses,
including
salaries,
benefits,
and
stock based
compensation,
related
to
executive
management,
finance,
legal,
and human
resource
functions
and other general
corporate
expenses,
including
rent,
depreciation
and
amortization associated
with
long-lived
assets, information technology costs, and utilities. General and administrative expenses are partially offset by payments we received in the form of government grants and other reimbursement agreements, including our agreement with the ARMI in which we are reimbursed for certain expenses incurred.
Other (Expense) Income
Other (expense) income consists of interest expense, interest income, and loss on issuance of convertible preferred stock. Interest expense consists primarily of interest on outstanding long-term debt under our Ex-Im Credit Facility and amortization of the associated deferred financing fees, and interest on our sale-leaseback transaction. Interest income consists of interest earned on cash and cash equivalent balances. The loss on issuance of convertible preferred stock relates to the difference between the fair value and aggregate proceeds received from the issuance of Series C and C-1
Preferred Stock
.
Income Tax Expense
Our provision for income taxes consists of an estimate of federal, state, and foreign income taxes based on enacted federal, state, and foreign tax rates, as adjusted for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities, and changes in tax law. Due to the level of historical losses, we maintain a valuation allowance against U.S. federal and state deferred tax assets as it has been concluded it is more likely than not that these deferred tax assets will not be realized.
Comparison of Results
for
the Three and Nine Months Ended
September
30, 2025 and 2024
The following
table
presents
selected
financial
information
for
the
periods
presented
(dollars
in thousands):
Three Months Ended September 30,
Increase
(Decrease)
Increase
(Decrease)
Nine Months Ended September 30,
Increase
(Decrease)
Increase
(Decrease)
2025
2024
($)
(%)
2025
2024
($)
(%)
Revenues
Product revenue
$
2,917
$
799
2,118
*
$
7,993
$
1,395
6,598
*
Service revenue
6,001
2,267
3,734
*
16,490
9,260
7,230
78
%
8,918
3,066
5,852
*
24,483
10,655
13,828
*
Cost of revenues
Product revenue
1,660
662
998
*
2,255
1,250
1,005
80
%
Service revenue
1,081
527
554
*
3,415
2,049
1,366
67
%
2,741
1,189
1,552
*
5,670
3,299
2,371
72
%
Gross margin
Product revenue
1,257
137
1,120
*
5,738
145
5,593
*
Service revenue
4,920
1,740
3,180
*
13,075
7,211
5,864
81
%
6,177
1,877
4,300
*
18,813
7,356
11,457
*
Operating Expenses
Research and development
56,371
54,043
2,328
4
%
170,484
146,152
24,332
17
%
General and administrative
30,380
20,834
9,546
46
%
86,241
57,399
28,842
50
%
Total operating expenses
86,751
74,877
11,874
16
%
256,725
203,551
53,174
26
%
Loss from operations
(80,574)
(73,000)
7,574
10
%
(237,912)
(196,195)
41,717
21
%
Other (expense) income
Interest expense
(3,464)
(2,908)
556
19
%
(9,214)
(8,502)
712
8
%
Interest income
2,628
1,035
1,593
*
7,348
5,740
1,608
28
%
Loss on issuance of convertible preferred stock
(355,551)
—
355,551
*
(355,551)
—
355,551
Total other income (expense)
(356,387)
(1,873)
354,514
*
(357,417)
(2,762)
354,655
*
Loss before income taxes
(436,961)
(74,873)
362,088
*
(595,329)
(198,957)
396,372
*
Income tax expense
(253)
(191)
62
32
%
(580)
(246)
334
*
Net loss
$
(437,214)
$
(75,064)
$
362,150
*
$
(595,909)
$
(199,203)
$
396,706
*
*
Percentage increase (decrease) is not meaningful
Revenues
Product revenues increased by $2.1 million during the three months ended September 30, 2025 compared to the three months ended September 30, 2024. The increase was attributable to new contracts with commercial customers to deliver electronic propulsion motors, batteries, flight control systems and GSE totaling $2.9 million, offset by $0.8 million due to a non-recurring contract for the forward operating base (the “FOB”) completed in 2024, which did not repeat in 2025.
Service revenues increased by $3.7 million during the three months ended September 30, 2025 compared to the three months ended September 30, 2024. The increase was attributable to new and ongoing contracts with commercial customers of $3.7 million related to engineering and consulting services to support our customers’ research and development activities, $0.3 million related to priority access to the Company’s charging stations, offset by a reduction of revenue of $0.3 million related to completion of a project for the U.S. government during 2024.
Product
revenues
increased
by $
6.6
million
during
the
nine months ended September 30, 2025 compared
to the
nine months ended
September 30,
2024.
The increase
was
attributable
to new and ongoing contracts with commercial customers to deliver electronic propulsion motors, batteries, flight control systems, GSE totaling $7.7 million offset by $1.1 million due to a non-recurring contract for the
FOB completed in 2024, which did not repeat in 2025
.
Service
revenues
increased
by
$
7.2
million,
or
78%
,
during
the
nine months ended September 30, 2025 compared to
the
nine months ended September 30, 2024. The increase
was attributable
to new and ongoing contracts with commercial customers of $4.1
million related to engineering and consulting services to support our customers’ research and development activities,
$
0.9 million related to priority access to the Company’s charging stations, and a net increase of $2.2 million from U.S. government customers during 2025
.
Cost of Revenues
Cost
of
product
revenues
increased
by
$
1.0
million
during
the
three
months
ended
September
30,
2025
compared
to
the
three
months
ended
September
30,
2025
due
to an increase in labor and material costs to fulfill contracts with commercial customers of $1.5 million, partially offset by a decrease in labor and material costs due to completion of the FOB during 2024 of $0.5 million.
Cost
of
service
revenues
increased
by
$
0.6
million during
the
three
months
ended September 30, 2025 compared
to
the
three
months
ended
September
30,
2024.
The increase
was
attributable
to an increase of $
0.7
million in labor and material costs to fulfill contracts with commercial customers, partially offset by a decrease in labor and material costs of $
0.1
million due to completion of service agreements with the U.S. government during 2024.
Cost
of
product
revenues
increased
by $
1.0
million, or
80%,
during
the
nine months ended September 30, 2025 compared
to the
nine months ended September 30, 2024 due to an increase in labor and material costs to fulfill contracts with commercial customers of $2.1 million, partially offset by a decrease in labor and material costs due to completion of the FOB during 2024 of $1.1 million.
Cost
of
service
revenues
increased
by
$
1.4
million,
or
67%
,
during
the
nine months ended
September 30,
2025 compared
to
the
nine months ended September 30, 2024. The increase
was attributable
to an increase of $
2.3
million in labor and material costs to fulfill contracts with commercial and U.S. government customers, partially offset by a decrease in labor and material costs of $
0.9
million due to completion of service agreements with the U.S. government during 2024.
Gross Margin
Product revenue
gross margin increased by $
1.1
million
during
the
three
months
ended September
30,
2025 compared
to
the
three
months
ended
September
30, 2024. The increase
was
attributable
to increased product revenue of $
2.1
million, offset by an increase of $
1.0 million of cost of product revenue. Product revenue gross margin as a percentage of product revenue increased due to
a more favorable mix of customer contracts during 2025.
Service
revenue
gross
margin
increased
by
$
3.2
million
during
the three
months
ended
September
30,
2025
compared
to
the
three
months
ended
September
30,
2024.
The
increase
was
attributable
to higher service revenue of
$
3.7
million, partially offset by an increase in cost of service revenue. Service revenue gross margin as a percentage of service revenue increased due to a more favorable mix of customer contracts during 2025.
Product revenue gross
margin
increased
by
$
5.6
million during
the
nine months ended September 30, 2025 compared
to
the
nine months ended
September 30,
2024.
The
increase
was
attributable
to
increased product revenue of $
6.6
million as well as a more favorable mix of customer contracts during 2025.
Service
revenue
gross
margin
increased
by
$
5.9
million,
or
81%
,
during
the
nine months ended
September 30,
2025
compared
to
the
nine months
ended
September 30,
2024.
The
increase
was
attributable
to
higher service revenue of
$
7.2
million, partially offset by an increase in cost of service revenue. Service revenue gross margin as a percentage of service revenue increased due to a more favorable mix of customer contracts during 2025.
Research
and
development
expenses
increased
$
2.3
million,
or
4%
,
for
the
three
months
ended September 30, 2025
compared
to
the
three
months
ended
September
30,
2024.
The
increase
was
attributable
to continued spend related to the development, testing, certification, and prototype production of our electric aircraft. As part of these efforts, we incurred increased professional fees of $1.9 million, labor costs of $0.5 million, and depreciation expense of $1.1 million resulting from our investment in our production facility, offset by a decrease in expenses for parts, materials, and other expenses of $1.2 million based on timing of prototype production related purchases.
Research and development expenses increased $
24.3
million, or
17%
, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The increase was attributable to continued spend related to the development, testing, certification, and prototype production of our electric aircraft. As part of these efforts, we incurred increased expenses for parts and materials of $
11.5
million, labor costs including stock based compensation of $7.5
million, depreciation and amortization of $
4.2
million resulting from our investment in our production facility, and other expenses of $
1.1
million.
General and Administrative
Expenses
General
and
administrative
expenses
increased
$
9.5
million,
or
46%
,
for
the
three
months
ended
September
30,
2025 compared
to the
three
months
ended September 30, 2024. The increase
was
attributable
to an increase in labor costs of $4.1 million due to increased headcount, and $2.4 million of professional fees, and $3.0 million of other administrative costs.
General and administrative expenses increased $
28.8
million, or
50%
, for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The increase was attributable to increased stock based compensation expense of $6.7
million, salaries and benefits of $
8.3
million due to increased headcount and bonus expense, $7.1 million of professional fees, and $6
.7
million of other administrative costs.
Other (Expense) Income
Interest
expense
increased
$
0.6
million,
or
19%
,
for
the
three
months
ended
September
30,
2025
compared
to
the three
months
ended
September
30,
2024. The increase
was attributable
to the timing of the last borrowing under our Ex-Im Credit Facility which occurred during September 2024 and sale-leaseback transaction which occurred during July 2025.
Interest expense increased $
0.7
million, or
8%,
for the nine months ended September 30, 2025 compared to the nine months ended September 30, 2024. The increase was attributable to the timing of the last borrowing under our Ex-Im Credit Facility which occurred during September 2024 and sale-leaseback transaction which occurred during July 2025.
Interest
income
increased
$
1.6
million
for
the
three
and nine
months
ended
September
30,
2025
compared to the
three
and nine
months
ended September 30, 2024. The
increase
was
primarily due
to market fluctuation and the associated increase in our higher average cash and cash equivalents balances held in interest-earning accounts, comparatively.
Loss on issuance of convertible preferred stock
is
$
355.6
million and $
0
for
the
three and nine
months
ended September 30, 2025 and September 30, 2024 due to the difference between the fair value and aggregate proceeds received from the issuance of Series C and C-1
Preferred Stock
in the three
months
ended
September
30,
2025.
Income
Tax Expense
Income
tax
expense
increased by less than
$
0.1
million, or
32%,
for
the
three
months
ended September 30, 2025 compared
to the
three months
ended September 30, 2024, primarily
due to an increase in the foreign provision on foreign earnings.
Income
tax
expense
increased
$
0.3
million
for
the
nine months ended
September 30,
2025
compared
to the
nine months ended
September 30,
2024,
primarily
due to an increase in the foreign provision on foreign earnings.
We
define EBITDA as net loss, adjusted for interest income, interest expense, income tax expense, and depreciation and amortization. We define Adjusted EBITDA as EBITDA adjusted for loss on issuance of convertible preferred stock, stock based compensation expense, warrant expense, loss on disposal of property and equipment, and IPO readiness costs.
In addition to traditional financial metrics, we use EBITDA and Adjusted EBITDA to help us evaluate our business. We believe that these non-GAAP measures provide useful information to investors because they allow for greater transparency into what measures we use in operating our business and measuring our performance and enable comparison of financial trends and results between periods where items may vary independent of business performance. These non-GAAP measures are presented for supplemental informational purposes and should not be considered as substitutes for or superior to financial information presented in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude certain expenses that are required by GAAP to be recorded in our financial statements, and they are subject to inherent limitations as they reflect the exercise of judgment by our management about which expenses are excluded or included in determining these non-GAAP financial measures. Further, non-GAAP financial measures are not standardized. It may not be possible to compare these financial measures with other companies’ non-GAAP financial measures having the same or similar names. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures. In addition, investors are encouraged to review our interim condensed consolidated financial statements and the notes thereto in their entirety and not to rely on any single financial measure.
A reconciliation between net loss, the most directly comparable GAAP financial measure, and the non-GAAP financial measures is as follows (in thousands):
Three Months Ended September 30,
Nine Months Ended September 30,
2025
2024
2025
2024
Net loss
$
(437,214)
$
(75,064)
$
(595,909)
$
(199,203)
Increase (decrease) as adjusted for :
Interest income
(2,628)
(1,035)
(7,348)
(5,740)
Interest expense
3,464
2,908
9,214
8,502
Income tax expense
253
191
580
246
Depreciation and amortization expense
5,794
3,888
16,314
11,313
EBITDA
$
(430,331)
$
(69,112)
$
(577,149)
$
(184,882)
Loss on issuance of convertible preferred stock
355,551
—
355,551
—
Stock based compensation expense
5,205
4,567
16,819
9,172
Warrant expense
308
—
308
—
Loss on disposal of property and equipment
932
351
2,473
591
IPO readiness costs
(1)
760
—
1,310
—
Adjusted EBITDA
$
(67,575)
$
(64,194)
$
(200,688)
$
(175,119)
(1)
Represents legal and accounting related expenses incurred in connection with becoming a public company.
Liquidity
and Capital
Resources
We
have
incurred
net
losses
and
negative
operating
cash
flows
from
operations
since
we were formed
and began
designing
our
electric
aircraft
in
2018,
and
we
expect
to
continue
to
incur
losses
and
negative
operating cash
flows
for
the
foreseeable
future
until
we successfully
commence
sustainable
commercial
operations. Historically,
our
primary
sources
of
liquidity
have been borrowings
under
our Ex-Im Credit
Facility,
equity
financings, government
funding
and
consideration
from
contracts
with
customers as well as the proceeds from our IPO and the sale-leaseback transaction.
To
date,
our
primary
use
of
capital
has been for
contractual
obligations
and the
development
of our electric
aircraft,
GSE
and Enabling
Technologies.
As
of
September
30,
2025,
we had cash
and cash
equivalents
of
$687.6
million.
Until
we generate
sufficient operating cash flow
to fully
cover our operating expenses,
working
capital
needs and planned capital expenditures,
or
if
circumstances
evolve
differently
than
anticipated,
we
expect
to
utilize
a combination
of equity and
debt
financings
to
fund
any
future
remaining
capital
needs.
If
we
raise
funds
by
issuing
equity
securities, dilution
to
stockholders
may
result.
Any equity
securities
issued
may
also
provide
for
rights,
preferences,
or privileges
senior
to
those
of
holders
of
c
ommon
s
tock.
If
we raise
funds
by issuing
debt
securities,
these
debt securities
may
have
rights,
preferences,
and
privileges
senior
to
those
of
preferred
and
common
stockholders. The
terms
of
debt
securities
or borrowings
could
impose
significant
restrictions
on our operations.
The capital markets
have
in
the
past,
and
may
in the
future,
experience
periods
of volatility
that
could
impact
the
availability and
cost
of
equity
and
debt
financing.
We
can
give
no
assurances
that
we
will
be able
to secure
such additional sources
of
funds
to
support
our operations,
or, if
such funds
are
available
to us, that
such additional
financing
will be
sufficient
to
meet
our
needs.
See Note 1
“Nature of Operations and Liquidity”
to the
Company’s
unaudited
interim
condensed
consolidated
financial statements included elsewhere in this Quarterly Report on Form 10-Q,
audited
annual consolidated
financial
statements included in the Prospectus,
and “Risk factors—Our
business
plan
requires
a significant
amount
of
capital.
We
expect
to
require
additional
future
funding
to support
our operations
and implementation
of
our
growth
plans
and
we
may
be
unable
to access
the
capital
and credit
markets
or borrow on affordable
terms
to obtain
additional
capital
that
we may
require” included in “Risk Factors” in the Prospectus.
Our
principal
uses
of cash
in recent
periods
were to fund our research
and development
activities,
personnel cost
and
support
services,
including
our
battery,
motor
and charging
services.
Near-term
cash
requirements
will also
include
spending
on
research
and development
of emerging
technologies,
strategic
growth initiatives, including
obtaining
certifications
and
manufacturing
our
aircraft,
commercial
and
go-to
market
infrastructure. We
do
not
have
material
cash
requirements
related
to current
contractual
obligations.
As such, our cash requirements
are
highly
dependent
upon
management’s
decisions
about
the
pace
and focus
of both our short
and long-term
spending.
Cash requirements
can fluctuate
based
on business
decisions
that
could
accelerate
or defer spending, including
the
timing
or
pace
of
certification,
investments,
infrastructure
and production
of electric
aircraft,
GSE and
Enabling
Technologies.
Our
future
capital
requirements
will
depend on many
factors,
including
our revenue growth rate,
the
timing
and the
amount
of cash
or grants
received
from
our customers
or governmental
entities, respectively,
the
expansion
of
sales
and
marketing
activities,
and the
timing
and extent
of spending
to support development
efforts, including collaboration agreements.
Capital
Expenditures
During
the
nine months
ended
September 30,
2025
and
2024,
we
used
$
24.4
million
and
$
51.3
million
in cash,
respectively,
to fund capital
expenditures.
We anticipate
incurring additional
capital
expenditures
during
the
remaining
portion
of
the
year
ending
December
31,
2025,
primarily related
to the purchase of aircraft, production
tooling
, f
acility
improvements, and buildings.
Sources of Cash
The following
table
sets
forth
our cash
flows
for
the
periods
indicated
(in thousands):
For the Nine Months Ended
September,
2025
2024
Net cash (used in) provided by:
Operating
activities
(183,386)
(165,262)
Investing
activities
(24,367)
(51,301)
Financing
activities
598,380
15,328
Effect
of currency
translation
on cash,
cash
equivalents and restricted
cash
(20)
(24)
Net increase (decrease) in cash, cash equivalents and restricted cash
We
continue
to
experience
negative
cash
flows
from
operations
as
we
develop
our
electric
aircraft,
GSE and Enabling
Technologies
and
prepare
for
the
future
commercialization
of our products
and services.
Our cash
flows from
operating
activities
are
significantly
affected by
our expenditures
in research
and development
and overhead
manufacturing
related
to
the
scaling
of
our
operations.
Our
operating
cash
flows
are
also
affected
by our
working
capital
needs
to support
growth, personnel
related
expenditures,
accounts
payable
and other
current assets
and liabilities.
For the
nine months
ended
September 30, 2025, net
cash
used in operating
activities
was $
183.4
million,
primarily due
to
a net loss of $
595.9 million, offset by non-cash charges including
$
16.3 million related to depreciation and amortization,
$
16.8 million related to stock based compensation, $355.6 million related to loss on issuance of convertible preferred stock, and $4.5 million of other non-cash charges, partially offset by $19.4 million of cash provided by changes in operating assets and liabilities
.
For
the
nine months ended September 30, 2025, cash
provided
by changes
in operating
assets
and liabilities
of
$19.4
million
was primarily
attributable
to
an increase in accounts payable,
accrued
expenses, and current liabilities of
$18.0
million.
For the
nine months ended September 30, 2024, net
cash
used in operating
activities
was $
165.3
million,
primarily due to a net loss of $
199.2 million, partially offset by non-cash charges including
$
11.3 million related to depreciation and amortization,
$
9.2 million related to stock based compensation, and
$
2.5 million of other non-cash charges, partially offset by $10.9 million of cash provided by changes to operating assets and liabilities
.
For the
nine months ended September 30,
2024,
cash provided by changes
in operating
assets
and liabilities
of $
10.9
million
was primarily attributable
to
an increase in accounts payable, accrued expenses, and current liabilities of
$
7.6 million.
Investing
Activities
We
continue
to
experience
negative
cash
flows
from
investing
activities
as we build
our infrastructure
and purchase
equipment
to
support
the
development
and commercialization
of our electric
aircraft
and charging network.
Cash
flows
used in investing
activities
primarily
relate
to capital
expenditures
to support
our growth in operations,
including
expenditures
related
to
the
construction
and expansion
of our charging
and production facilities,
acquisitions
of machinery
and equipment,
tooling
and technology
infrastructure,
partially
offset
by proceeds
from
sales
of
property
and
equipment,
customer
funding
from
GSE
installation
and
governmental grants.
For
the
nine months ended
September 30,
2025,
net
ca
s
h
used
in
investing
activities
was
$
24.4
million,
primarily due to net purchases of property and equipment of $
25.7
million.
For
the
nine months
ended
September 30, 2024, net
cash
used in investing
activities
was $
51.3
million,
primarily due to net purchases of property and equipment of $
51.7 million
.
Financing Activities
For the
nine months ended September 30, 2025, net
cash
provided
by financing
activities
was $
598.4
million, primarily
due
to the proceeds received from issuances of our Series C and Series C-1
Preferred Stock
of
$150.4 million and $422.4 million, respectively, and proceeds received from the sale-leaseback transaction of $32.7 million.
For the
nine months ended September 30, 2024, net
cash
provided
by financing
activities
was $
15.3
million, primarily
due
to
the proceeds from the issuance of our promissory note of $
15.5
million
.
Ex-Im Credit
Facility
On
December
13,
2023,
we
entered
into
our
Ex-Im
Credit
Facility,
which provided
commitments
in an aggregate amount
equal
to $170.1 million
to, among
other
things,
finance
certain
of our goods and services
costs
related
to the
design,
planning,
permitting,
and construction
of the
Final
Assembly
Facility.
Our Ex-Im Credit Facility
matures
on December
20,
2038.
As
of September 30, 2025, we have fully
drawn down the
Ex-Im
Credit
Facility
in an aggregate
principal amount
equal
to $151.2 million,
net
of exposure
fees
of $18.9 million.
The
Company’s
obligations
under
the
Ex-Im
Credit
Agreement
are
secured
by
the
“Collateral”
(as
defined
in
the Ex-Im Credit
Agreement),
which
generally
consists
of
the
Final
Assembly
Facility.
The
Company
is
no
longer
able
to
draw
down
further
funds
under
our Ex-Im
Credit
Facility
given
that
each
of (a)
the
commitment
availability
period
for
drawing
funds
thereunder
has
expired
in
accordance with
its
terms
and (b)
the
commitments
under
our
Ex-Im
Credit
Facility
have
been
fully
drawn.
Eac
h
disbursemen
t
unde
r
ou
r
Ex-Im
Credi
t
Facilit
y
accrue
s
interes
t
a
t
a
fixe
d
interes
t
rat
e
o
f
5.52
%
pe
r
annum
,
which pe
r
annu
m
interes
t
rat
e
i
s
subjec
t
t
o
increas
e
i
n
accordanc
e
wit
h
th
e
term
s
o
f
th
e
Ex-Im
Credi
t
Agreemen
t
upo
n
the occurrenc
e
o
f
a
“Paymen
t
Default
”
and/o
r
a
“Trigge
r
Event
”
(eac
h
suc
h
ter
m
a
s
define
d
i
n
th
e
Ex-Im
Credi
t
Agreement). Inclusiv
e
o
f
th
e
timin
g
o
f
drawdowns
,
exposur
e
fees
,
an
d
deb
t
issuanc
e
costs
,
th
e
effectiv
e
pe
r
annu
m
interes
t
rat
e
on outstandin
g
borrowing
s
unde
r
ou
r
Ex-Im
Credi
t
Facilit
y
wa
s
7.32%
.
Interes
t
unde
r
ou
r
Ex-Im
Credi
t
Facilit
y
i
s
payabl
e
quarterl
y
in arrear
s
o
n
eac
h
Marc
h
20
,
Jun
e
20
,
Septembe
r
20
,
an
d
Decembe
r
2
0
o
f
eac
h
year.
The
Company
may,
from
time
to
time,
prepay
all
or
any
part
of
the
outstanding
principal
balance
of
the disbursements made
pursuant
to
our
Ex-Im
Credit
Facility,
subject
to
a
prepayment
premium
in
an
amount
equal
to:
the amount by
which
(a)
the
amount of
the
prepaid principal
is
less
than
(b)
the
sum
of
the
present
values, discounted in
accordance
with
the
terms
of
the
Ex-Im
Credit
Agreement,
of
(x)
the
installments
of
principal
being
prepaid,
plus (y)
the
amounts
of
interest
which
would
otherwise have
accrued
on
such
principal
to
the
remaining interest payment
dates.
The
Ex-Im
Credit
Agreement
provides
for
mandatory
amortization
payments
with
respect
to
the
principal
amount
of funds disbursed
pursuant
to
our
Ex-Im
Credit
Facility,
in
the
amounts
and on
the
terms
set
forth
in
the
Credit
Agreement, such
that
such
principal
amount
is
repaid
in
fifty-four
(54)
successive
quarterly
installments. Such
amortization payments
are
required
to
be
made
by
the
Company
on
each
March
20,
June
20,
September 20,
and
December 20 of
each
year,
commencing on
September
20,
2025.
Furthermore,
the
Ex-Im
Credit
Agreement
includes
mandatory prepayments
in
connection
with
certain
sanctions-related
events,
events
of
loss,
and
collateral
destruction
events.
Our
Ex-Im
Credit
Facility
documents
contain
affirmative
and
negative
covenants,
including,
among
other
things, delivery
of
annual
audited
financial
statements and
Make
More
in
America
Initiative annual
reports,
maintenance of
certain
governmental
consents,
licenses,
permits,
authorizations, and
approvals,
compliance
with
laws (including
sanctions)
and
the
“MMIA
Compliance
Plan”
(as
defined
in
the
Ex-Im
Credit
Agreement),
and
maintenance
of insurance,
along
with
restrictions
on
the
incurrence
of
liens,
asset
dispositions, acquisitions, changes
in
nature
of business,
mergers,
consolidations,
dissolutions,
and
sales,
and
other
customary covenants, in
each
case,
subject
to customary
exceptions.
The
Ex-Im
Credit
Agreement also
includes
events
of
default
relating
to
customary
matters
(and customary
notice
and
cure
periods),
including,
among
other
things,
nonpayment
of
principal,
interest,
or
other
amounts,
violation
of
covenants
,
incorrectness
of
representations and warranties
in
any material
respect, cross-default
with
respect
to material
indebtedness
and
other
Ex-Im
indebtedness,
bankruptcy,
material
judgments, and
certain
ERISA
events.
Contractual
Obligations
and
Commercial
Commitments
Our contractual obligations and commercial commitments consist primarily of long-term debt obligation and operating leases. These contractual obligations impact our short-term and long-term liquidity and capital needs. As of September 30, 2025, there were no material changes to our contractual obligations and commercial commitments from those described in Note 5 “Notes Payable” and Note 6 “Leases” in the audited consolidated financial statements included within our Prospectus, other than as disclosed in Note 6 “Leases” to the interim condensed consolidated financial statements included in this Quarterly Report on Form 10-Q.
Critical
Accounting Estimates
Our
consolidated
financial
statements
are
prepared
in
accordance
with
GAAP. In connection
with preparing our consolidated
financial
statements
and interim
condensed
consolidated
financial
statement
s
, we are
required
to make
assumptions
and estimates
about
future
events
and apply
judgments
that
affect
the reported
amounts of assets, liabilities, revenue,
expense
and
the related
disclosures. We base
our assumptions, estimates and judgments
on
historical
experience,
current
trends
and
other
factors
that
management
believes
to
be
relevant
at the
time
we prepare our
consolidated
financial statements.
On a regular
basis, management reviews the accounting
policies,
assumptions,
estimates
and
judgments
to
ensure
that
our
consolidated
financial
statements are
presented
fairly
and
in
accordance
with
GAAP. However,
because
future
events
and
their
effects
cannot
be determined
with certainty,
actual
results
could
differ
materially
from
our assumptions
and estimates. There have been no changes to our critical accounting estimates as disclosed in the audited consolidated financial statements included in the Prospectus.
See
Note
2
“Basis
of
Presentation
and Accounting
Policies”
in the
Notes to our audited
historical consolidated
financial
statements
in the Prospectus
and interim
condensed
consolidated
financial
statements
included elsewhere in this
Quarterly Report on Form 10-Q,
for
a discussion
of recent
accounting
pronouncements.
Emerging
Growth Company Status
Under
the
JOBS Act,
we
are an
“emerging
growth
company,”
which allows
us to have an extended
transition
period
for
complying
with new or revised
accounting standards pursuant
to
Section
107(b)
of
the
JOBS
Act.
Thus,
an
emerging
growth
company
can
delay
the
adoption
of certain
accounting
standards
until
those
standards
would
otherwise
apply
to
private
companies.
We
have
elected to
take
advantage
of the
extended
transition
period
to comply
with new or revised
accounting
standards.
Electing to
use
the
phase-in
periods
permitted
by
this
election
may
make
it
difficult
to
compare
our financial
statements
to those
of
non-emerging
growth
companies
and
other
emerging
growth
companies
that
have
opted
out
of
the longer
phase-in
periods
under
Section
107
of
the
JOBS Act
and
who
will
comply
with
new
or revised
financial accounting
standards.
We will remain an emerging growth company until the earliest of (i) the last day of our first fiscal year in which we have total annual gross revenues of $1.235 billion or more, (ii) the last day of the first fiscal year in which we become a “large accelerated filer” as defined in Rule 12b-2 under the Exchange Act, with at least $700 million of equity securities held by non-affiliates as of the end of the last business day of the second quarter of that fiscal year, (iii) the date on which we have issued, in any three-year period, more than $1.0 billion in non-convertible debt securities, or (iv) the last day of our fiscal year after the fifth anniversary of the date of the completion of the IPO.
Off-Balance
Sheet Arrangements
We have no material
off-balance
sheet
arrangements.
Item 3.
Quantitative
and Qualitative
Disclosure
about Market
Risks
Market
risk
is
the
risk
of loss
arising
from
adverse
changes
in market
rates
and prices.
Currently,
our market risks
relate
to
potential
changes
in
the
fair
value
of our long-term
debt
due to fluctuations
in applicable
market interest
rates and inflation.
Going
forward
our market
risk
exposure
generally
will
be limited
to those
risks
that
arise
in the normal
course
of
business,
as we do not engage
in speculative,
non-operating
transactions,
nor do we utilize financial
instruments
or derivative
instruments
for
trading
purposes.
Interest
Rate Risk
We
had
cash
and
cash
equivalents
totaling
$687.6
million
as
of
September
30,
2025.
These amounts
were invested in
standard
checking,
demand
deposit
and money
market
funds.
The cash
and cash
equivalents
are
held
for working capital
purposes.
We do not enter
into
investments
for
trading
or speculative
purposes.
We believe
that we
do
not
have
any
material
exposure
to
changes
in
the
fair
value
as
a
result
of
changes
in
interest
rates
due
to the
short
term
nature
of
our
cash
equivalents.
Declines
in
interest
rates,
however, would reduce
future
interest income.
Credit
Risk
Financial
instruments
that
subject
us
to
significant
concentrations
of
credit
risk
consist
primarily
of cash
and money-market
cash
equivalents.
Our
cash
is
held
in
accounts
with
multiple
financial
institutions
that
we believe are
creditworthy.
These
amounts
at
times
may
exceed
federally
insured
limits.
We
have
not
experienced
any credit
losses
in such accounts
and do not believe
it
is
exposed
to any significant
credit
risk
on these
funds.
Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this Quarterly Report on Form 10-Q.
Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of September 30, 2025, our disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and Rule 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2025 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Limitations on Effectiveness of Controls and Procedures
Our management, including our Chief Executive Officer and Chief Financial Officer, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at the reasonable assurance level. However, the effectiveness of any internal control over financial reporting is subject to inherent limitations, including the exercise of judgment in designing, implementing, operating, and evaluating the controls and procedures, and the inability to eliminate misconduct completely. Accordingly, any system of internal control over financial reporting, no matter how well designed and operated, can only provide reasonable, not absolute assurance that its objectives will be met. In addition, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. We intend to continue to monitor and upgrade our internal controls as necessary or appropriate for our business, but cannot assure that such improvements will be sufficient to provide us with effective internal control over financial reporting.
See
Part I, Item 1,
Note 7 “Commitments and Contingencies” to the interim condensed consolidated financial statements, which is incorporated herein by reference.
From time to time, the Company is party to certain legal actions and claims arising in the ordinary course of business. While the outcome of these events cannot be predicted with certainty, management does not currently expect these matters to have a materially adverse effect on the financial position or results of operations of the Company.
Item 1A. Risk Factors
There have been no material changes to the risk factors disclosed in “Risk Factors” in the Prospectus.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities
Unregistered Sale of Securities
For the three months ended September 30, 2025, the Company issued 3,978,505 shares of previously authorized Series C Preferred Stock and expanded the shares authorized and issued pursuant to the Series C Preferred Stock offering by 4,235,947 shares that provided aggregate net proceeds of approximately $147.4 million.
In September 2025, the Company entered into a Series C-1 Preferred Stock purchase agreement. Through September 30, 2025, the Company issued 16,723,599 shares of Series C-1 Preferred Stock to GE Aerospace for total proceeds of $300.0 million. The Company issued an additional 6,821,852 shares of Series C-1 Preferred Stock for aggregate net proceeds of approximately $122.4 million to new and previous investors, including board members and their associated companies.
See Note 8 “Convertible Preferred Stock and Stockholders’ Equity Convertible Preferred Stock and Stockholders’ Equity” to our audited consolidated financial statements in the Prospectus for additional information regarding the terms of conversion for the convertible preferred stock.
In connection with the closing of the Series C-1 Financing, on September 26, 2025, the Company issued warrants to GE Aerospace to purchase 2,552,467 shares of the Company’s Class A common stock at a pre-split exercise price of $0.01 per share.
See Note 14 “Related Party Transactions” to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information on the terms of conversion for the GE Warrants.
The offers and sales of the above securities were deemed to be exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act, Regulation D or Regulation S promulgated thereunder. The foregoing transaction did not involve any underwriters, underwriting discounts or commissions or any public offering. The recipients of the above securities represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof. Appropriate legends were placed upon any stock certificates issued in these transactions.
Use of Proceeds from Registered Securities
On November 5, 2025, the Company completed its IPO of 34,330,882 shares of the Company’s Class A common stock at a price to the public of $34.00 per share, inclusive of the exercise in full by the underwriters to purchase from the Company 4,477,941 shares of Class A common stock. The Company received net proceeds from the IPO of approximately $1,103
million
, after deducting approximately $63.9 million in underwriting discounts and commissions. All shares sold were registered pursuant to a registration statement on Form S-1 (File No. 333-290570), as amended (the “Registration Statement”) which became automatically effective pursuant to Section 8(a) of the Securities Act of 1933, as amended. Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC acted as representatives of the underwriters for the IPO. The offering terminated after the sale of all the securities registered pursuant to the Registration Statement.
There has been no material change in the use of proceeds from our IPO as described in our Prospectus.
During the three months ended September 30, 2025 no director or officer of BETA
adopted
, modified, or
terminated
any Rule 10b5–1 trading arrangement or any non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) and (c) of Regulation S-K.
Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Customers and Suppliers of BETA Technologies, Inc.
Beta
No Customers Found
No Suppliers Found
Bonds of BETA Technologies, Inc.
Price Graph
Price
Yield
Insider Ownership of BETA Technologies, Inc.
company Beta
Owner
Position
Direct Shares
Indirect Shares
AI Insights
Summary Financials of BETA Technologies, Inc.
Beta
(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)